ATMI Invests in Sterile Fill and Connector Technology - - BioPharm International

ADVERTISEMENT

ATMI Invests in Sterile Fill and Connector Technology



ATMI, a provider of single-use bioprocess solutions, has invested in sterile connector and sterile fill technology developed by Medical Instill Technologies (Medinstill), a provider of transfer and packaging solutions for high purity fluids at unmatched safety levels.

The investments focus on the INTACT family of products developed by Medinstill. These technologies will be deployed in sterile filling, sterile multiple-dose dispensing, sterile transfer, and packaging sterilization solutions.

In other news, ATMI has introduced a line of pyrogen-free vials in collaboration with Disposable Lab, a Bordeaux, France contract manufacturing organization

Source: ATMI

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Novartis and GSK Trade Assets
April 22, 2014
Lilly to Acquire Novartis Animal Health
April 22, 2014
EMA Warns of Falsified Herceptin Vials
April 16, 2014
Mallinckrodt to Acquire Questcor Pharmaceuticals
April 16, 2014
Center for Biologics Evaluation and Research Relocates
April 11, 2014
Author Guidelines

Click here